Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ARYx Therapeutics, Inc. | 130,000 | reported | 25 Feb 2010 | tx 5+221,000−1,250 |
| Audentes Therapeutics, Inc. | 300 | reported | 20 Jun 2018 | tx 13+112,500−25,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 20 Jun 2018 | EXERCISE | Audentes Therapeutics, Inc. | 300 | 2.19 USD | |
| 20 Jun 2018 | SALE | Audentes Therapeutics, Inc. | 300 | 46.02 USD | |
| 20 Jun 2018 | EXERCISE | Audentes Therapeutics, Inc. | 4,700 | 2.19 USD | |
| 20 Jun 2018 | SALE | Audentes Therapeutics, Inc. | 4,700 | 45.25 USD | |
| 20 Jun 2018 | EXERCISE | Audentes Therapeutics, Inc. | 5,000 | 0.00 USD | deriv |
| 16 Nov 2017 | GRANT_AWARD | Audentes Therapeutics, Inc. | 50,000 | 0.00 USD | deriv |
| 27 Sept 2017 | EXERCISE | Audentes Therapeutics, Inc. | 3,750 | 2.19 USD | |
| 27 Sept 2017 | SALE | Audentes Therapeutics, Inc. | 3,750 | 30.00 USD | |
| 27 Sept 2017 | EXERCISE | Audentes Therapeutics, Inc. | 3,750 | 0.00 USD | deriv |
| 15 Sept 2017 | SALE | Audentes Therapeutics, Inc. | 3,750 | 25.00 USD | |
| 15 Sept 2017 | EXERCISE | Audentes Therapeutics, Inc. | 3,750 | 2.19 USD | |
| 15 Sept 2017 | EXERCISE | Audentes Therapeutics, Inc. | 3,750 | 0.00 USD | deriv |
| 25 Jan 2017 | GRANT_AWARD | Audentes Therapeutics, Inc. | 50,000 | 0.00 USD | deriv |
| 25 Feb 2010 | GRANT_AWARD | ARYx Therapeutics, Inc. | 130,000 | 0.00 USD | deriv |
| 21 Dec 2009 | GIFT | ARYx Therapeutics, Inc. | 1,000 | 0.00 USD | |
| 21 Dec 2009 | GIFT | ARYx Therapeutics, Inc. | 1,250 | 0.00 USD | |
| 18 Feb 2009 | GRANT_AWARD | ARYx Therapeutics, Inc. | 60,000 | 0.00 USD | deriv |
| 06 Feb 2008 | GRANT_AWARD | ARYx Therapeutics, Inc. | 30,000 | 0.00 USD | deriv |